Novartis has 25 blockbusters in the pipeline: CEO

May 23, 2019

ZURICH (Reuters) – Novartis has 25 potential blockbuster treatments in development, the company said ahead of a management event in the United States on Thursday.

“Our pipeline is industry-leading with more than 25 potential blockbusters and this pace of innovation positions Novartis well for the future”, said Novartis Chief Executive Vas Narasimhan in a statement.

(Reporting by Silke Koltrowitz)

Comments (No)

Leave a Reply